New Study Finds Working Memory Training Produces Lasting Improvements In Kids With Attention Deficits
Stephen Bozylinski, Ph.D, a clinical psychologist and director of the ADHD Clinic of Southern California, released findings from a new open label study demonstrating the effectiveness of Cogmed Working Memory Training to sustainably improve attention and executive processing in children with ADHD. The study found that significant improvements in working memory, mental stamina and inhibition and significant decreases in ADHD symptoms remained six to eight months after the training.
VYVANSE Demonstrates Significant Efficacy For Treatment Of ADHD For Up To 12 Hours After Administration
Shire plc (LSE: SHP, NASDAQ: SHPGY, TSX: SHQ), the global specialty biopharmaceutical company, announced that Biological Psychiatry published the results of a study showing VYVANSE™ (lisdexamfetamine dimesylate), the first prodrug stimulant for the treatment of Attention Deficit Hyperactivity Disorder (ADHD), provided significant efficacy in children for up to 12 hours.
Dore: Ground Breaking Drug-Free Treatment For ADHD, USA
U.S. researchers discover that the brains of children and teenagers with Attention Deficit Hyperactivity Disorder (ADHD) are three years delayed compared with typically developing children. "What I wouldn't take away from this study is: 'Just sit and wait three years and your kid will be OK. We know ADHD is a real problem for children, their families and schools, and it does need treatment, '" says Dr.
Auriga Laboratories Obtains Rights To Market And Sell A New Product Indicated For The Treatment Of ADHD
Auriga Laboratories, Inc. (OTCBB:ARGA), a specialty pharmaceutical company, announced today the signing of a license agreement with Outlook Pharmaceuticals, Inc., pursuant to which Auriga will have the exclusive rights to market and sell a new product indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in the United States.
Studies Review Smoking Among College Freshmen And Tobacco Use By Adolescents With ADHD
A supplemental issue of Nicotine and Tobacco Research published yesterday includes a variety of key findings on the smoking habits of college freshmen; nicotine dependence; the use of tobacco by individuals with attention- deficit/ hyperactivity disorder, depression and anxiety; and the challenges of so-called "reduced-exposure" tobacco products.
The Significant Impact of Adult ADHD On Social, Financial And Personal Aspects Of Life
Nationally recognized Attention Deficit Hyperactivity Disorder (ADHD) authority Russell Barkley, Ph.D., has embarked on a national speaking tour to discuss the symptoms of ADHD in adults and the potentially serious consequences these symptoms may have on the life of an adult living with this disorder. ADHD is believed to affect an estimated 8.1 percent of adults, or 9.2 million adults across the U.S. based on a retrospective survey of adults aged 18 to 44, projected to the full U.S.
Additional Dosage Strengths Of Vyvanse Approved By FDA
Shire plc (LSE: SHP, NASDAQ: SHPGY, TSX: SHQ), the global specialty biopharmaceutical company, has announced that it has received approval from the U.S. Food and Drug Administration (FDA) for three additional dosage strengths for the attention deficit hyperactivity disorder (ADHD) treatment, VYVANSE™ (lisdexamfetamine dimesylate).
Attention Seeking Confused With ADHD
Teachers and parents need to beware of confusing children who are attention seeking with those who suffer from attention-deficit hyperactivity disorder (ADHD).This is the finding of Dr Nigel Mellor an independent Educational Psychologist who presented his research on Thursday 10 January 2008, at the British Psychological Society's Division of Child and Educational Psychology Annual Conference in Bournemouth.
Study Raises Questions About Diagnosis, Medical Treatment Of ADHD
A new UCLA study shows that only about half of children diagnosed with attention-deficit hyperactivity disorder, or ADHD, exhibit the cognitive defects commonly associated with the condition. The study also found that in populations where medication is rarely prescribed to treat ADHD, the prevalence and symptoms of the disorder are roughly equivalent to populations in which medication is widely used.
Finding The Causes Of ADHD - New Study Launched By Norwegian Institute Of Public Health
An unprecedented ADHD study was launched on Wednesday 16th January to find causes and early warning signs of ADHD among pre-school age children. ADHD is frequently diagnosed but little is known about the causes, despite all the published research. Today there are no diagnostic criteria for ADHD in children under 6 years of age. The ADHD study intends to address many unanswered questions around the causes of this condition.